Moreover, PRR11 has been regarded as a potential biomarker target for cancer treatment in the future, since it shows a significant association with poor prognosis in human cancers, such as gastric cancer [13] and cholangiocarcinoma [14]. This evidence concerns the gene PRR11 and gastric cancer.